Clinical trial
Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for…
NCT00373711 · Stanford University, Other · Withdrawn
Key facts
| NCT number | NCT00373711 |
|---|---|
| Title | Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA |
| Official title | Comparison of I-124 PET/CT, F-18 FDG PET/CT and I-123 Whole Body Scintigraphy for Recurrent Thyroid Cancer Detection |
| Lead sponsor | Stanford University, Other |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Thyroid Cancer |
| Intervention type | Drug |
| Interventions | Iodine-124, Iodine-123, F-18 FDG |
| Enrollment | 0 |
| Start date | May 1, 2007 |
| First posted | Sep 8, 2006 |
| Last update posted | Jun 21, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: